Vaxcyte, Inc.
Status: Publicly traded
Direct answer
Vaxcyte, Inc. is publicly traded on NASDAQ under the ticker PCVX.
Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease...
Can you invest in Vaxcyte, Inc.?
Yes. Vaxcyte, Inc. is publicly traded on NASDAQ under the ticker PCVX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Vaxcyte, Inc.
Detailed equity research is provided by MarketSnap.